Latest Breaking News On - Digital psychiatry - Page 2 : vimarsana.com

FDA clears first digital treatment for depression, but experts caution that research is still early

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesJohn krausJohn torousBrian iacovielloDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

FDA clears first digital treatment for depression, but experts caution that research is still early - WSVN 7News | Miami News, Weather, Sports

(CNN) The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.Rejoyn, made by<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-clears-first-digital-treatment-for-depression-but-experts-caution-that-research-is-still-early/">Read More</a>

United statesJohn torousBrian iacovielloJohn krausDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

Depression: First digital treatment approved – What is and what Rejoyn app does to mobile phones

Depression: First digital treatment approved – What is and what Rejoyn app does to mobile phones
athens-times.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from athens-times.com Daily Mail and Mail on Sunday newspapers.

United statesBrian iacovielloJohn torousDrug organizationAmerican foodEmotional faces memory taskClick therapeuticsEmotional faces memoryDigital psychiatryBeth israel deaconess medical center

FDA clears first digital treatment for depression, but experts caution research is still early

Rejoyn is an app intended for use alongside antidepressant medications for people with major depressive disorder.

United statesBrian iacovielloJohn krausJohn torousDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical centerOb marketComputer science

Smartphone app approved as treatment for depression 5 things to know about Rejoyn

It is “designed to act like physical therapy for the brain,” a scientific advisor says.

New yorkUnited statesDavid benshoof kleinJohn torousBrian iacovielloDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskMount sinaiDigital psychiatryBeth israel deaconess medical centerBenshoof kleinMajor depressive disorderFood and drug administrationEgions of the brain